DRKS00033279招募中不适用
Discovery of antigen and toxin profiles in Clostridioides difficile disease - PaPrep_C.diff.
Abteilung für Infektions- und Tropenmedizin, LMU Klinikum München0 个研究点目标入组 130 人开始时间: 2023年12月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •signed written consent before undertaking any study specific activity
- •available for the first two sample time points ( in the C.diff. group); 3rd timepoint is optional
- •aged between 18-99 years
排除标准
- •unable to provide consent
- •underlying psychological disease
- •Hepatitis A diagnosis
研究者
相似试验
招募中
Unknown
Correlation testing of toxin-producing Clostridioides difficile toxin B detection reagents in stool samples.Infectious diseasesJPRN-jRCT1032230481Suzuki Hiromichi700
招募中
不适用
Molecular biological study to elucidate pathogenicity of epicardial adipose tissueJPRN-UMIN000043455Hiroshima University50
尚未招募
4 期
Immunity against Influenza virus disease and safety of FluQuadri (marketed vaccine with protection against 4 types of influenza virus) in children of age between 6 and 12 monthsCTRI/2021/10/037161Seth GS Medical College and KEM Hospital
进行中（未招募）
1 期
Immunogenicity, molecular profiling and safety of a marketed quadrivalent influenza vaccine (Vaxigrip Tetra) administered by the intramuscular route in children 3-11 years oldImmune response to infuenza vaccine in young childrenEUCTR2021-003804-42-NOHelse Bergen HF50
已完成
4 期
Immunity against Influenza virus disease and safety of FluQuadri (marketed vaccine with protection against 4 types of influenza virus) in participants 60 years of age and olderCTRI/2020/09/027913Seth GSMC and KEM Hospital100